In this issue:
Adjuvant CT might benefit stage II CDX2-negative CRC
Adding irinotecan to 5FU-based CT in older patients
Examining the role of neoadjuvant therapy in rectal cancer
Cytoreductive surgery + HIPEC in peritoneal metastases
Obesity, aspirin, and CRC risk in Lynch syndrome
Colon cancer: drink more coffee?
Drug sequence more important than drug exposure in mCRC
XELOX regimen: DFS and OS benefit in stage III colon cancer
Cognitive impairment in CRC
10-year MOSAIC data support FOLFOX in stage III CRC
Please login below to download this issue (PDF)